AMG
Beyond's analysis on AMG
- — Mercedes‑AMG unveils a high‑performance CLE 646 to appeal to combustion‑engine enthusiasts amid growing EV skepticism
- — Man Group PLC discloses its stake in AMG Critical Materials N.V. via a Form 8.3 filing
- — Man Group PLC disclosed its holdings in AMG Critical Materials N.V. via a Form 8.3 filing
Recent news mentioning AMG
- — AMG: Höchstleistung für die Verbrenner-Fraktion – Das kann der Mercedes-AMG CLE 646
- — Amgen (AMGN) Fell 5% on a Drug That Isn’t Even Its Own. Here’s the Lp(a) Bet Now in Question.
- — Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
- — Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
- — Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- — Positive Lung Cancer Data Lifts the Case for Amgen and AstraZeneca
- — Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
- — Supersportler: Nur 30 Stück: Mercedes-AMG CLE 646 sprintet auf 310 km/h
- — Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
- — Here Are Thursday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Amgen, AngloGold Ashanti, Caterpillar, Chewy, Meta Platforms, Novartis, NVIDIA, SK hynix, and More
- — Amgen's Forward Multiple Looks Cheap Until You Price The Margins It Assumes
- — Could AstraZeneca (AZN)’s Stronger Growth Make it a Better Bet than Amgen (AMGN)?